Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Probing T cell membrane organization using dimeric MHC-Ig complexes.

Fahmy TM, Bieler JG, Schneck JP.

J Immunol Methods. 2002 Oct 1;268(1):93-106. Review.

PMID:
12213346
2.

Monitoring antigen-specific T cells using MHC-Ig dimers.

Schneck JP.

Immunol Invest. 2000 May;29(2):163-9.

PMID:
10854185
3.

Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.

Fahmy TM, Bieler JG, Edidin M, Schneck JP.

Immunity. 2001 Feb;14(2):135-43.

4.

Association of MHC class II-peptide complexes with plasma membrane lipid microdomains.

Poloso NJ, Roche PA.

Curr Opin Immunol. 2004 Feb;16(1):103-7. Review.

PMID:
14734117
5.

Class I major histocompatibility complexes loaded by a periodate trigger.

Rodenko B, Toebes M, Celie PH, Perrakis A, Schumacher TN, Ovaa H.

J Am Chem Soc. 2009 Sep 2;131(34):12305-13. doi: 10.1021/ja9037565.

PMID:
19655751
6.

Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.

Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K.

J Biol Chem. 2006 Apr 14;281(15):10439-47. Epub 2006 Feb 2.

7.
8.
9.
10.

MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.

Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I.

Int Immunol. 2003 Nov;15(11):1291-9.

PMID:
14565927
11.
12.

Orientation of the Ig domains of CD8 alpha beta relative to MHC class I.

Devine L, Sun J, Barr MR, Kavathas PB.

J Immunol. 1999 Jan 15;162(2):846-51.

13.

Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

Ge Q, Stone JD, Thompson MT, Cochran JR, Rushe M, Eisen HN, Chen J, Stern LJ.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13729-34. Epub 2002 Oct 8.

14.

Immune selection in murine tumors. Ph.d thesis.

Svane IM, Engel AM.

APMIS Suppl. 2003;(106):1-46.

PMID:
12739251
15.

MHC/peptide tetramer-based studies of T cell function.

Xu XN, Screaton GR.

J Immunol Methods. 2002 Oct 1;268(1):21-8. Review.

PMID:
12213339
16.

Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.

Delaguillaumie A, Marin-Esteban V, Setterblad N, Leh LJ, Assier E, Gelin C, Charron D, Galy A, Mooney N.

Eur J Immunol. 2008 Apr;38(4):1096-105. doi: 10.1002/eji.200737455.

17.

MHC class I antigen presentation--recently trimmed and well presented.

Flutter B, Gao B.

Cell Mol Immunol. 2004 Feb;1(1):22-30. Review.

18.

Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding.

Nolte-'t Hoen EN, Amoroso MG, Veenstra J, Grosfeld-Stulemeyer MC, van Eden W, Broeren CP, Wauben MH.

Eur J Immunol. 2004 Dec;34(12):3359-69.

19.

Kinetics of MHC-CD8 interaction at the T cell membrane.

Huang J, Edwards LJ, Evavold BD, Zhu C.

J Immunol. 2007 Dec 1;179(11):7653-62.

20.

Generation and use of alternative multimers of peptide/MHC complexes.

Hugues S, Malherbe L, Filippi C, Glaichenhaus N.

J Immunol Methods. 2002 Oct 1;268(1):83-92. Review.

PMID:
12213345

Supplemental Content

Support Center